These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15241610)

  • 21. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
    Toris CB; Zhan G; Camras CB
    Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
    Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
    Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aqueous humor dynamics in monkeys with laser-induced glaucoma.
    Toris CB; Zhan GL; Wang YL; Zhao J; McLaughlin MA; Camras CB; Yablonski ME
    J Ocul Pharmacol Ther; 2000 Feb; 16(1):19-27. PubMed ID: 10673127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
    Nilsson SF; Drecoll E; Lütjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of Action of Selective Laser Trabeculoplasty and Predictors of Response.
    Gulati V; Fan S; Gardner BJ; Havens SJ; Schaaf MT; Neely DG; Toris CB
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1462-1468. PubMed ID: 28264102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative human aqueous dynamics study between black and white subjects with glaucoma.
    Beltran-Agullo L; Alaghband P; Rashid S; Gosselin J; Obi A; Husain R; Lim KS
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9425-30. PubMed ID: 21980001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of topical epinephrine on aqueous humor dynamics in the cat.
    Wang YL; Toris CB; Zhan G; Yablonski ME
    Exp Eye Res; 1999 Apr; 68(4):439-45. PubMed ID: 10192801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of selective laser trabeculoplasty on aqueous humor dynamics in patients with ocular hypertension and primary open-angle glaucoma.
    Beltran-Agullo L; Alaghband P; Obi A; Husain R; Lim KS
    J Glaucoma; 2013 Dec; 22(9):746-9. PubMed ID: 22668978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of latanoprost on outflow facility in the mouse.
    Crowston JG; Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2240-5. PubMed ID: 15223801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow.
    Vanlandigham BD; Brubaker RF
    Am J Ophthalmol; 1998 Aug; 126(2):191-6. PubMed ID: 9727512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aqueous humor dynamics during the day and night in healthy mature volunteers.
    Liu H; Fan S; Gulati V; Camras LJ; Zhan G; Ghate D; Camras CB; Toris CB
    Arch Ophthalmol; 2011 Mar; 129(3):269-75. PubMed ID: 21402980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.
    Diestelhorst M; Roters S; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1997 Jan; 235(1):20-6. PubMed ID: 9034838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.